Home > Insider Trading > Filing (0001214659-16-014641)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1649989	Oncobiologics Inc.	ONS	Biological Products, (No Disgnostic Substances) (2836)	383982704

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1663253	A. Scott Gangloff	C/O Oncobiologics, Inc. 7 Clarke Drive Cranbury NJ 08521	Svp, Development & Mfrg	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Restricted Stock Units	Disposition	2016-11-09	115,942	$0.00	0	No	4	C	Direct
Common Stock	Acquisiton	2016-11-09	115,942	$0.00	115,942	No	4	M	Direct
Common Stock	Disposition	2016-11-11	37,369	$3.75	78,573	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	M	Direct
No	4	S	Direct

Footnotes

Granted pursuant to the Issuer's 2015 Equity Incentive Plan.
Each restricted stock unit ("RSU") represents the right to receive, at settlement, one (1) share of the Issuer's common stock.
The RSUs vest upon the first to occur of (x) a change of control as defined in the award agreement and (y) the expiration of the 6 month lock-up period following the Issuer's initial public offering, in each case subject to continued service through such event.
Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on November 9, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.